<DOC>
	<DOCNO>NCT01277133</DOCNO>
	<brief_summary>This single arm , prospective , observational study ass correlation time start chemotherapy start Avastin ( bevacizumab ) treatment progression-free survival patient previously untreated metastatic breast cancer . Patients follow 12 month progressive disease occur .</brief_summary>
	<brief_title>An Observational Study The Correlation Between Time Initiation Avastin ( Bevacizumab ) Treatment And Progression-Free Survival Patients With Metastatic Breast Cancer ( CRONOS 2 )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Adult patient , &gt; /=18 year age Previously untreated metastatic breast cancer Scheduled start 1st line chemotherapeutic treatment ECOG performance status 01 Any condition include contraindication list Avastin Prior chemotherapy metastatic breast cancer Adjuvant/neoadjuvant chemotherapy radiochemotherapy nonmetastatic malignancy complete &lt; 6 month prior treatment start</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>